Adverse events in placebo arm. by Judith I. Tsui (5983160)

Subjects:

Adverse events in gabapentin arm. by Judith I. Tsui (5983160)

Subjects:

Cullin-1/5 degradation requires Gal-lectin-mediated contact with macrophage. by Attinder Chadha (11414273)

Chun Fai Martin Cheng: How can we decrease metabolism in the New Zealand green-lipped mussels, Perna canaliculus, for better transport? by Cheng Martin (11717816)

Mean Capability, Opportunity, and Motivation scores by DAT and country among health care workers. by Kevin Guzman (16474985)

Temporal profiles of the key BO-NN features. by Julia Berezutskaya (9080269)

“…<p><b>(a)</b> Autocorrelation profiles of 53 key BO-NN features. Per feature, a black line shows the time point where the autocorrelation drops below .5. …”

Fig 5 - by Jacob C. Jentzer (4746999)

Structure of P-YOLOv5s-GRNF. by Zhongjian Xie (4633099)

Mean value of ENSS and subscales. by Phu Dinh Vu (19429477)

Subjects:

Evaluation of virus CD4/CCR5 utilization using Affinofile cells. by Yiying Zhang (198443)

Fig 5 - by Héctor Raúl Olivares-Sánchez (13014866)

The standard deviation of the mean total population abundance was calculated at each time step. by Cyrine Chenaoui (22177098)

Pathway associated with decreased inflammation. by Monica N. Mweetwa (17054522)

Mean frequency of the cultural trait <i>T</i> in the population when <i>T</i> decreases fertility. by Laurel Fogarty (143721)

Difference in mean Capability scores by age (≥55 vs. <55 years) among people with TB. by Kevin Guzman (16474985)

Difference in mean Motivation scores by age (≥55 vs. <55 years) among people with TB. by Kevin Guzman (16474985)

Difference in mean Opportunity scores by age (≥55 vs. <55 years) among people with TB. by Kevin Guzman (16474985)

Inhibition of ABCG2 decreases SP cells, but not sphere-forming ability. by Noriko Kawai (6694010)

Presentation_1_Airway macrophages display decreased expression of receptors mediating and regulating scavenging in early cystic fibrosis lung disease.pdf by Lisa J. M. Slimmen (16464600)

“…Percentage of AMs expressing lipid scavenger CD36 was low overall (mean 20.1% ± 16.5) and did not correlate with other factors. …”

Comparative experiment of different YOLOv5 versions. by Zhongjian Xie (4633099)